Cite
HARVARD Citation
Anders Olsen, T. et al. (n.d.). 223 Racial differences in outcomes for metastatic renal cell carcinoma (mRCC) patients managed on immune-checkpoint inhibitor (ICI) therapy. Journal for immunotherapy of cancer. p. A242. [Online].